NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition

S Mirzaei, S Saghari, F Bassiri, R Raesi… - Journal of cellular …, 2022 - Wiley Online Library
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …

[HTML][HTML] Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies

A Mehmandar-Oskuie, K Jahankhani… - Biomedicine & …, 2023 - Elsevier
Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …

LncRNA BCCE4 Genetically Enhances the PD‐L1/PD‐1 Interaction in Smoking‐Related Bladder Cancer by Modulating miR‐328‐3p‐USP18 Signaling

R Zheng, F Gao, Z Mao, Y Xiao, L Yuan… - Advanced …, 2023 - Wiley Online Library
Identification of cancer‐associated variants, especially those in functional regions of long
noncoding RNAs (lncRNAs), has become an essential task in tumor etiology. However, the …

[HTML][HTML] p53 activates the lipoxygenase activity of ALOX15B via inhibiting SLC7A11 to induce ferroptosis in bladder cancer cells

X Li, W Xiong, Y Wang, Y Li, X Cheng, W Liu - Laboratory Investigation, 2023 - Elsevier
Bladder cancer is a malignant tumor of the urinary system and is one of the most common
cancers worldwide. Lipoxygenases are closely related to the development of various …

Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives

J Song, Y Ge, X Sun, Q Guan, S Gong, M Wei, J Niu… - Molecular cancer, 2022 - Springer
Cancer is a type of malignant affliction threatening human health worldwide; however, the
molecular mechanism of cancer pathogenesis remains to be elusive. The oncogenic …

[HTML][HTML] Using Sankey diagrams to explore the trend of article citations in the field of bladder cancer: research achievements in China higher than those in the United …

YL Lee, TW Chien, JC Wang - Medicine, 2022 - journals.lww.com
Background: Urology authors are required to evaluate research achievements (RAs) in the
field of bladder cancer (BC). However, no such bibliometric indices were appropriately …

Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence

MDA Paskeh, S Mirzaei, S Orouei, A Zabolian… - International Journal of …, 2021 - Elsevier
Recently, microRNAs (miRNAs) have shown to be potential therapeutic, diagnostic and
prognostic targets in disease therapy. These endogenous non-coding RNAs contribute to …

METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m7G-modified miR-760-dependent manner

H Xie, M Wang, H Yu, H Wang, L Ding, R Wang… - Cell Death …, 2022 - nature.com
methylguanosine (m7G) modification is recently found to conservatively exist in RNA internal
position besides mRNA caps and mediates the various RNA metabolisms. As the core …

Biological functions and clinical significance of long noncoding RNAs in bladder cancer

Y Zhang, X Chen, J Lin, X Jin - Cell death discovery, 2021 - nature.com
Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …

Biomarkers of bladder cancer: cell-free DNA, epigenetic modifications and non-coding RNAs

S Harsanyi, ZV Novakova, K Bevizova… - International Journal of …, 2022 - mdpi.com
Bladder cancer (BC) is the 10th most frequent cancer in the world. The initial diagnosis and
surveillance of BC require a combination of invasive and non-invasive methods, which are …